glutathione helps prevent serious chronic illnesses lise alschuler Frontiers Role of Micronutrient Supplementation in

On October 4, 2016, Alnylam Pharmaceuticals terminated revusiran, its RNAi therapeutic for Transthyretin amyloidosis with cardiomyopathy, following 19 patient fatalities in a phase 3 trial,, 17 in the treatment cohort compared to 2 in the placebo group,, resulting in a $3.6 billion decline in market capitalization and investor doubt regarding the RNAi platform

I like it

Photosensitizers with Aggregation-Induced Emission: Materials and Biomedical Applications

In conclusion, we have demonstrated that the application of a standardized bioinformatics workflow, including QC, statistical analysis and pathway analysis, to publicly available datasets, serves as a powerful and cost and time effective approach to reveal the most relevant biological mechanisms underpinning prostate cancer development and progression

Hepatic 2-globulin localizes to the cytosol of rat proximal tubule cells

Y., Jefferis, J